Purisima, Veronica B.

HRN: 25-06-52  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2024
CEFTRIAXONE 1G (VIAL)
05/21/2024
05/28/2024
IV
2g
Daily
Pelvic Mass, T/C Pelvic Fracture
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractBone & Joint    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: